Rubella Virus and its Effects on the Developing Nervous System

  • Jerry S. Wolinsky


Rubella was initially recognized as a distinct disease entity in the early nineteenth century1. For nearly 150 years, rubella virus was considered to cause only a mild morbilliform rash, occasional fever and a rather predictable lymphadenopathy. Predominantly a childhood disease, rubella is known to be endemic throughout the world and is associated with epidemics which occur in irregular fashion.


Immune Complex Bovine Viral Diarrhoea Virus Rubella Virus Congenital Rubella Syndrome Rubella Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Cooper, L. Z. (1985). The history and medical consequences of rubella. Rev. Infect. Dis., 7, S2 - S10PubMedCrossRefGoogle Scholar
  2. 2.
    Gregg, N. M. (1941). Congenital cataract following German measles in the mother. Trans. Ophthalmol. Soc. Aust., 3, 35–46Google Scholar
  3. 3.
    Wesselhoeft, C. (1947). Rubella (German measles). N. Engl. J. Med., 236, 943–50PubMedCrossRefGoogle Scholar
  4. 4.
    Fenner, F. (1976). Classification and nomenclature of viruses. Intervirology, 7, 1–115PubMedCrossRefGoogle Scholar
  5. 5.
    Shope, R. E. (1985). Epidemiology: Mechanisms of cause, distribution and transmission of viral disease. In Fields, B. N. (ed.) Virology. pp. 145–52. ( New York: Raven Press )Google Scholar
  6. 6.
    Westaway, E. G., Brinton, M. A., Gaidamouich, S. Y., Horzinek, M. C., Igarashi, A., Kaariainen, L., Luou, D. K., Porterfield, J. S., Russell, P. K. and Trent, D. W. (1985). Flaviviridae. Intervirology, 24, 183–92PubMedCrossRefGoogle Scholar
  7. 7.
    Chew-Lim, M., Scott, T. and Webb, H. E. (1978). An ultrastructural study of cerebellar lesions induced in mice by three inoculations of avirulent Semliki Forest virus. Acta Neuropathol., 41, 55–9PubMedCrossRefGoogle Scholar
  8. 8.
    Dal Canto, M. C. and Rabinowitz, S. G. (1981). Central nervous system demyelination in Venezuelan equine encephalomyelitis infection. An experimental model of virus-induced myelin injury. J. Neurol. Sci., 49, 397–418CrossRefGoogle Scholar
  9. 9.
    Seay, A. R. and Wolinsky, J. S. (1983). Ross River virus-induced demyelination: II. Ultrastructural studies. Ann. Neurol., 14, 559–68PubMedCrossRefGoogle Scholar
  10. 10.
    Snowdon, W. A., Parsonson, I. M. and Broun, M. L. (1975). The reaction of pregnant ewes to inoculation with mucosal disease virus of bovine origin. J. Comp. Pathol., 85, 241–51PubMedCrossRefGoogle Scholar
  11. 11.
    Brinton, M. A. (1980). Non-arbo togaviruses. In Schlesinger, R. W. (ed.) The Togaviruses. pp. 623–66. ( New York: Academic Press )Google Scholar
  12. 12.
    Potts, B., Elder, G., Sever, J., Sawyer, M. and Osburn, B. (1986). Border disease of sheep: An animal model for virus-induced hypomyelination. Neurology, 36, S204Google Scholar
  13. 13.
    Matthews, R. E. F. (1982). Classification and nomenclature of viruses. Third report of the International Committee on the Taxonomy of Viruses. Intervirology, 17, 1–199CrossRefGoogle Scholar
  14. 14.
    Parkman, P. D., Buescher, R. L. and Arnstein, M. S. (1962). Recovery of rubella virus from army recruits. Proc. Soc. Exp. Biol. Med., 111, 225–30PubMedGoogle Scholar
  15. 15.
    Weller, T. H. and Neva, F. A. (1962). Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc. Soc. Exp. Biol. Med., 111, 215–25Google Scholar
  16. 16.
    Bardeletti, G., Kessler, N. and Aymard-Henry, N. (1975). Morphology. Biochemical analysis and neuraminidase activity of rubella virus. Arch. Virol., 49, 175–86PubMedCrossRefGoogle Scholar
  17. 17.
    Payment, P., Ajdukovic, D. and Pavilanis, V. (1975). Le virus de la ruberole. I. Morphologie et proteines structurales. Can. J. Microbiol., 21, 703–9PubMedCrossRefGoogle Scholar
  18. 18.
    Murphy, F. A., Halonen, P. E. and Harrison, A. K. (1968). Electron microscopy of the development of rubella virus in BHK-21 cells. J. Virol., 2, 1223–7PubMedGoogle Scholar
  19. 19.
    Oshiro, L. S., Schmidt, N. J. and Lennette, E. H. (1969). Electron microscopic studies of rubella virus. J. Gen. Virol., 5, 205–10PubMedCrossRefGoogle Scholar
  20. 20.
    Murphy, F. A. (1980). Togavirus morphology and morphogenesis. In Schlesinger, R. W. (ed.) The Togaviruses. pp. 241–316. ( New York: Academic Press )Google Scholar
  21. 21.
    Maes, R., Vaheri, A., Sedwick, D. and Plotkin, S. (1966). Synthesis of virus and macromolecules by rubella virus infected cells. Nature, 210, 384–6PubMedCrossRefGoogle Scholar
  22. 22.
    Olson, G. B., Dent, P. B., Rawls, W. E., South, M. A., Montgomery, J. R., Melnick, J. L. and Good, R. A. (1968). Abnormalities of in vitro lymphocyte responses during rubella virus infections. J. Exp. Med., 128, 47–68PubMedCrossRefGoogle Scholar
  23. 23.
    Chantier, J. K. (1979). Rubella virus: Intracellular polypeptide synthesis. Virology, 98, 275–8CrossRefGoogle Scholar
  24. 24.
    Potter, J. E., Banatavala, J. E. and Best, J. (1973). Interferon studies with Japanese and U.S. rubella strains. Br. J. Med., 1, 197–9CrossRefGoogle Scholar
  25. 25.
    Maassab, H. F. and Cochran, K. W. (1964). Rubella virus: Inhibition in vitro with amantadine hydrochloride. Science, 145, 1443–4PubMedCrossRefGoogle Scholar
  26. 26.
    Rawls, W. E., Desmyter, J. and Melnick, J. L. (1968). Serologic diagnosis and fetal involvement in maternal rubella: Criteria for abortion. J. Am. Med. Assoc., 203, 627–31CrossRefGoogle Scholar
  27. 27.
    Rawls, W. E. and Melnick, J. L. (1966). Rubella virus carrier cultures derived from congenitally infected infants. J. Exp. Med., 123, 795–816PubMedCrossRefGoogle Scholar
  28. 28.
    Williams, M. P., Brawner, T. A. and Riggs, H. G. (1981). Characteristics of a persistent rubella infection in a human cell line. J. Gen Virol., 52, 321–8PubMedCrossRefGoogle Scholar
  29. 29.
    Norval, M. (1979). Mechanism of persistence of rubella virus in LLC-MK2 cells. J. Gen. Virol., 43, 289–98PubMedCrossRefGoogle Scholar
  30. 30.
    Bohn, E. M. and Van Alstyne, D. (1981). The generation of defective interfering rubella virus particles. Virology, 111, 549–54PubMedCrossRefGoogle Scholar
  31. 31.
    Vaheri, A. and Hovi, T. (1972). Structural proteins and subunits of rubella virus. J. Virol., 9, 10–16PubMedGoogle Scholar
  32. 32.
    Ho-Terry, L. and Cohen, A. (1980). Degradation of rubella virus envelope components. Arch. Virol., 65, 1–13PubMedCrossRefGoogle Scholar
  33. 33.
    Oker-Blom, C., Kalkkinen, N., Kaariainen, L. and Pettersson, R. F. (1983). Rubella virus contains one capsid protein and three envelope glycoproteins, El, E2a and E2b. J. Virol., 46, 964–73PubMedGoogle Scholar
  34. 34.
    Toivonen, V., Vainionpaa, R., Salmi, A. and Hyypia, T. (1983). Glycoproteins of rubella virus: Brief report. Arch. Virol., 77, 91–5PubMedCrossRefGoogle Scholar
  35. 35.
    Waxham, M. N. and Wolinsky, J. S. (1983). Immunochemical identification of rubella virus hemagglutinin. Virology, 126, 194–203PubMedCrossRefGoogle Scholar
  36. 36.
    Bowden, D. S. and Westaway, E. G. (1984). Rubella virus: Structural and non-structural proteins. J. Gen. Virol., 65, 933–43PubMedCrossRefGoogle Scholar
  37. 37.
    Waxham, M. N. and Wolinsky, J. S. (1985). A model of the structural organization of rubella virions. Rev. Infect. Dis., 7, S133 - S139PubMedCrossRefGoogle Scholar
  38. 38.
    Trudel, M., Ravaoarinoro, M. and Payment, P. (1980). Reconstitution of rubella hemagglutinin on liposomes. Can. J. Microbiol., 26, 899–904PubMedCrossRefGoogle Scholar
  39. 39.
    Ho-Terry, L., Cohen, A. and Tedder, R. S. (1984). Immunological characterization of rubella virion polypeptides. J. Med. Microbiol., 17, 105–9PubMedCrossRefGoogle Scholar
  40. 40.
    Waxham, M. N. and Wolinsky, J. S. (1985). Detailed immunologic analysis of the structural polypeptides of rubella virus using monoclonal antibodies. Virology, 143, 153–65PubMedCrossRefGoogle Scholar
  41. 41.
    Dent, P. B. and Rawls, W. E. (1971). Human congenital rubella: The relationship of immunologic aberation to viral persistence. Ann. N.Y. Acad. Sci., 181, 209–22CrossRefGoogle Scholar
  42. 42.
    Umino, Y., Sato, T. A., Katow, S., Matsuno, T. and Sugiura, A. (1985). Monoclonal antibodies directed to El glycoprotein of rubella virus. Arch. Virol., 83, 33–42PubMedCrossRefGoogle Scholar
  43. 43.
    Ho-Terry, L., Terry, G. M., Cohen, A. and Londesborough, P. (1986). Immunological characterization of the rubella El glycoprotein. Arch. Virol., 90, 145–52PubMedCrossRefGoogle Scholar
  44. 44.
    Pettersson, R. F., Oker-Blom, C., Kalkkinen, N., Kallio, A., Ulmanen, J., Kaariainen, L. and Partanen, P. (1985). Molecular and antigenic characteristics and synthesis of rubella virus structural proteins. Rev. Infect. Dis., 7, S140 - S149PubMedCrossRefGoogle Scholar
  45. 45.
    Kalkkinen, N., Oker-Blom, C. and Pettersson, R. F. (1984). Three gene codes for rubella virus structural proteins El, E2a and E2b. J. Gen. Virol., 65, 1549–57PubMedCrossRefGoogle Scholar
  46. 46.
    Green, K. Y. and Dorsett, P. H. (1986). Rubella virus antigens: Localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies. J. Virol., 57, 893–8PubMedGoogle Scholar
  47. 47.
    Dorsett, P. H., Miller, D. C., Green, K. Y. and Byrd, F. I. (1985). Structure and function of the rubella virus proteins. Rev. Infect. Dis., 7, S150–5156PubMedCrossRefGoogle Scholar
  48. 48.
    Sedwick, W. D. and Sokol, F. (1970). Nucleic acid of rubella virus and its replication in hamster kidney cells. J. Virol., 5, 478–89PubMedGoogle Scholar
  49. 49.
    Oker-Blom, C., Ulmanen, I., Kaarianen, L. and Pettersson, R. F. (1984). Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins. J. Virol., 49, 403–8PubMedGoogle Scholar
  50. 50.
    Wong, K. T., Robinson, W. S. and Merigan, T. C. (1969). Synthesis of viral-specific ribonucleic acid in rubella virus-infected cells. J. Virol., 4, 901–3PubMedGoogle Scholar
  51. 51.
    Hovi, T. and Vaheri, A. (1970). Infectivity and some physicochemical characteristics of rubella virus ribonucleic acid. Virology, 42, 1–8PubMedCrossRefGoogle Scholar
  52. 52.
    Schlesinger, M. J. (1985). Replication of togaviruses. In Fields, B. N. (ed.) Virology. pp. 1021–32. ( New York: Raven Press )Google Scholar
  53. 53.
    Oker-Blom, C. (1984). The gene order for rubella virus structural proteins is NH2–CE2-El-COOH. J. Virol., 51, 354–8PubMedGoogle Scholar
  54. 54.
    Alperti, G. and Schlesinger, M. J. (1978). Evidence for an autoprotease of Sinbis virus capsid protein. Virology, 90, 336–69Google Scholar
  55. 55.
    Bowden, D. S. and Westaway, E. G. (1985). Changes in glycosylation of rubella virus envelope proteins during maturation. J. Gen. Virol., 66, 201–6PubMedCrossRefGoogle Scholar
  56. 56.
    Schmidt, M. F. G. and Schlesinger, M. J. (1980). Relation of fatty acid attachment to the translation and maturation of vesicular stomatitis and Sindbis virus membrane glycoproteins. J. Biol. Chem., 255, 3334–9PubMedGoogle Scholar
  57. 57.
    Frey, T. K., Marr, L. D., Hemphill, M. L. and Dominguez, G. (1986). Molecular cloning and sequencing of the region of the rubella virus genome coding for glycoprotein El. Virology, 154, 228–32PubMedCrossRefGoogle Scholar
  58. 58.
    Blobel, G. and Dobberstein, B. (1975). Transfer of proteins across membranes; I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J. Cell. Biol., 67, 835–51PubMedCrossRefGoogle Scholar
  59. 59.
    Bardeletti, G., Tektoff, J. and Gauthern, O. (1979). Rubella virus maturation and production in two host cell systems. Intervirology, 11, 97–103PubMedCrossRefGoogle Scholar
  60. 60.
    Gaulton, G. N., Co, M. S., Royer, H. D. and Greene, M. I. (1985). Anti-idiotype antibodies as probes of surface receptors. Mol. Cell. Biochem., 65, 5–21Google Scholar
  61. 61.
    Nisonoff, A. and Lamoyi, E. (1981). Implications of the presence of an internal image of the antigen in anti-idiotypic antibodies: Possible application to vaccine production. Clin. Immunol. Immunopathol., 21, 397–406PubMedCrossRefGoogle Scholar
  62. 62.
    Green, R. H., Balsamo, M. R., Giles, J. P., Krugman, S. and Mirick, G. S. (1965). Studies of the natural history and prevention of rubella. Am. J. Dis. Child., 110, 348–65PubMedGoogle Scholar
  63. 63.
    Sever, J. L., Hardy, J. B., Nelson, K. B. and Gilkeson, M. R. (1969). Rubella in the collaborative perinatal research study. II. Clinical and laboratory findings in children through 3 years of age. Am. J. Dis. Child., 118, 123–32PubMedGoogle Scholar
  64. 64.
    Krugman, S. (1965). Rubella: Clinical and epidemiological aspects. Arch. Ges. Virusforsch., 16, 477–82PubMedCrossRefGoogle Scholar
  65. 65.
    Horstmann, D. M. (1976). Rubella. In Evans, A. S. (ed.) Viral Infections of Humans: Epidemiology and Control. pp. 409–27. ( New York: Plenum Publishing )CrossRefGoogle Scholar
  66. 66.
    Vesikari, T. (1972). Antibody response in rubella reinfection. Scand. J. Infect. Dis., 4, 11–16PubMedGoogle Scholar
  67. 67.
    Witte, J. J., Karchmer, A. W., Case, G., Herrmann, K. L., Abrutyu, E., Kassanoff, I. and Neill, J. S. (1969). Epidemiology of rubella. Am. J. Dis. Child., 118, 107–11PubMedGoogle Scholar
  68. 68.
    Bart, S. W., Stetler, H. C., Preblud, S. R., Williams, N. M., Orenstein, W. A., Bart, K. J., Hinman, A. R. and Herrmann, K. L. (1985). Fetal risk associated with rubella vaccine: An update. Rev. Infect. Dis., 7, S95 - S102PubMedCrossRefGoogle Scholar
  69. 69.
    Chantler, J. K. and Tingle, A. J. (1982). Isolation of rubella virus from human lymphocytes after acute natural infection. J. Infect. Dis., 145, 673–7PubMedCrossRefGoogle Scholar
  70. 70.
    Schiff, G. M. and Sever, J. L. (1966). Rubella: Recent laboratory and clinical advances. Prog. Med. Virol., 8, 30–61PubMedGoogle Scholar
  71. 71.
    Heggie, A. D. and Robbins, F. C. (1969). Natural rubella acquired after birth: Clinical features and complications. Am. J. Dis. Child., 118, 12–17PubMedGoogle Scholar
  72. 72.
    Horstman, D. M., Pajot, T. G. and Liebhaber, H. (1969). Epidemiology of rubella: Subclinical infection and occurrence of reinfection. Am. J. Dis. Child., 118, 133–6Google Scholar
  73. 73.
    Herrmann, K. L. (1985). Available rubella serologic tests. Rev. Infect. Dis., 7, S108–5112PubMedCrossRefGoogle Scholar
  74. 74.
    Heggie, A. D. (1978). Pathogenesis of the rubella exanthema: Distribution of rubella virus in the skin during rubella with and without rash. J. Infect. Dis., 137, 74–7PubMedCrossRefGoogle Scholar
  75. 75.
    Al-Nakib, W., Best, J. M. and Banatvala, J. E. (1975). Rubella-specific serum and nasopharyngeal responses following naturally acquired and vaccine-induced infection. Lancet, 1, 182–5PubMedCrossRefGoogle Scholar
  76. 76.
    Pernice, W., Schmitz, H., Schindera, F., Behrens, F. and Sedlacek, H. H. (1979). Antigen-specific detection of immune complexes in patients with hepatitis B, influenza A and rubella. Behring Inst. Mitt., 64, 102–8Google Scholar
  77. 77.
    Coyle, P. K., Wolinsky, J. S., Buimovici-Klein, E., Moucha, R. and Cooper, L. Z. (1982). Rubella-specific immune complexes after congenital infection and vaccination. Infect. Immun., 36, 498–503PubMedGoogle Scholar
  78. 78.
    Ziola, B., Lund, G., Meurman, O. and Salmi, A. (1983). Circulating immune complexes in patients with acute measles and rubella virus infections. Infect. Immun., 41, 578–83PubMedGoogle Scholar
  79. 79.
    McMorrow, L. E., Vesikari, T., Walman, S. R., Giles, J. P. and Cooper, L. Z. (1974). Suppression of the response of lymphocytes to phytohemagglutinin in rubella. J. Infect. Dis., 130, 464–9PubMedCrossRefGoogle Scholar
  80. 80.
    Buimovici-Klein, E., Vesikari, T., Santangelo, C. F. and Copper, L. Z. (1976). Study of the lymphocyte in vitro response to rubella antigen and phytohemagglutin by a whole blood method. Arch. Virol., 52, 323–31PubMedCrossRefGoogle Scholar
  81. 81.
    Honeyman, M. C., Forrest, J. M. and Dorman, D. C. (1972). Cell-mediated immune response following natural rubella vaccination. Clin. Exp. Immunol., 17, 665–71Google Scholar
  82. 82.
    Steele, R. W., Hensen, S. A., Vincent, M. M., Fuccillo, D. A. and Bellanti, J. A. (1974). Development of specific cellular and humoral immune responses in children immunized with live rubella. J. Infect. Dis., 130, 449–53PubMedCrossRefGoogle Scholar
  83. 83.
    Morag, A., Morag, B., Bernstein, J. M., Buetner, K. and Ogra, P. L. (1975). In vitro correlates of cell-mediated immunity in human tonsils after natural or induced rubella virus infections. J. Infect. Dis., 131, 409–16PubMedCrossRefGoogle Scholar
  84. 84.
    Buimovici-Klein, E. and Cooper, L. Z. (1985). Cell-mediated immune response in rubella infections. Rev. Infect. Dis., 7, S123 - S128PubMedCrossRefGoogle Scholar
  85. 85.
    Horstmann, D. M., Pajot, T. G. and Liebhaber, H. (1969). Epidemiology of rubella: Subclinical infection and occurrence of re-infection. Am. J. Dis. Child., 118, 133–6PubMedGoogle Scholar
  86. 86.
    Horstmann, D. M., Liebhaber, H., LeBouvier, G. L., Rosenberg, D. A. and Halstead, S. D. (1970). Rubella: Reinfection of vaccinated and naturally immune persons exposed in an epidemic. N. Engl. J. Med., 283, 771–8PubMedCrossRefGoogle Scholar
  87. 87.
    Miller, H. G., Stanton, J. B. and Gibbons, J. L. (1956). Para-infectious encephalomyelitis and related syndromes. Q. J. Med., 25, 427–505PubMedGoogle Scholar
  88. 88.
    Johnson, K. P., Wolinsky, J. S. and Ginsberg, A. H. (1978). Immune mediated syndromes of the nervous system related to viral infections. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology, Vol. 34, pp. 391–434. ( Amsterdam: North Holland )Google Scholar
  89. 89.
    Waxham, M. N. and Wolinsky, J. S. (1984). Rubella virus and its effects on the central nervous system. Neurol. Clin., 2, 367–85PubMedGoogle Scholar
  90. 90.
    Grahame, R., Armstrong, R. and Simon, N. (1983). Chronic arthritis associated with the presence of intrasynovial rubella virus. Ann. Rheum. Dis., 42, 2–13PubMedCrossRefGoogle Scholar
  91. 91.
    Chantler, J. K., Ford, D. K. and Tingle, A. J. (1981). Rubella associated arthritis: Rescue of rubella virus from peripheral blood lymphocytes two years post vaccination. Infect. Immun., 32, 1274–80PubMedGoogle Scholar
  92. 92.
    Tingle, A. J., Allen, M., Petty, R. E., Kettyls, G. D. and Chantler, J. K. (1986). Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA27/3 rubella immunization. Ann. Rheum. Dis., 45, 110–14PubMedCrossRefGoogle Scholar
  93. 93.
    Chantler, J. K., Ford, D. K. and Tingle, A. J. (1982). Persistent rubella infection and rubella-associated arthritis. Lancet, 1, 1323–5PubMedCrossRefGoogle Scholar
  94. 94.
    Grahame, R., Simons, N. A. and Wilton, J. M. A. (1981). Isolation of rubella virus from synovial fluid in five cases of seronegative arthritis. Lancet, 2, 649–52PubMedCrossRefGoogle Scholar
  95. 95.
    Ford, D. K., DeRoza, D. M. and Reid, G. D. (1982). Synovial mononuclear cell responses to rubella antigen in rheumatoid arthritis and unexplained persistent knee arthritis. J. Rheum., 9, 420–3PubMedGoogle Scholar
  96. 96.
    Chantler, J. K., Tingle, A. J. and Petty, R. E. (1985). Persistent rubella virus infection associated with chronic arthritis in children. N. Engl. J. Med., 313, 1117–23PubMedCrossRefGoogle Scholar
  97. 97.
    Cunningham, A, L. and Fraser, J. R. E. (1985). Persistent rubella virus infection of human synovial cells cultured in vitro. J. Infect. Dis., 151, 638–45PubMedCrossRefGoogle Scholar
  98. 98.
    Plotkin, S. A. (1969). Attenuation of RA27/3 rubella virus in WI-38 human diploid cells. Am. J. Dis. Child., 118, 178–85PubMedGoogle Scholar
  99. 99.
    Prinzie, A., Huggelen, C. and Gold, J. (1969). Experimental live attenuated rubella virus vaccine. Am J. Dis. Child., 118, 172–7PubMedGoogle Scholar
  100. 100.
    Center for Disease Control (1986). Rubella and congenital rubella syndrome-United States, 1984–1985. Morbid. Mortal. Weekly Rep., 35, 129–35Google Scholar
  101. 101.
    Miller, K. A. and Zager, T. D. (1984). Rubella susceptability in an adolescent female population. Mayo Clin. Proc., 59, 31–4PubMedGoogle Scholar
  102. 102.
    Hinman, A. R., Orenstein, W. A., Bart, K. J. and Preblud, S. R. (1983). Rational strategy for rubella vaccination. Lancet, 1, 39–43PubMedCrossRefGoogle Scholar
  103. 103.
    Tobin, J. O., Sheppard, S., Smithells, R. W., Milton, A., Noah, N. and Reid, D. (1985). Rubella in the United Kingdom, 1970–1983. Rev. Infect. Dis., 7, S47 - S52PubMedCrossRefGoogle Scholar
  104. 104.
    Clarke, M., Boustred, J., Schild, G. C., Seagroatt, V., Pollock, T. M., Finlay, S. E. and Barbara, J. A. J. (1979). Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet, 1, 1224–6PubMedCrossRefGoogle Scholar
  105. 105.
    Anderson, R. M. and Grenfell, B. T. (1985). Control of congenital rubella syndrome by mass vaccination. Lancet, 1, 827–8CrossRefGoogle Scholar
  106. 106.
    Halstead, S. B. and Diwan, A. J. (1971). Failure to transmit rubella virus vaccine. A doge-contact study in adults. J. Am. Med. Assoc., 215, 634–6CrossRefGoogle Scholar
  107. 107.
    Polk, B. F., Modlin, J. F. and White, J. A. (1982). A controlled comparison of joint reactions among women receiving one of two rubella vaccines. Am. J. Epidemiol., 115, 19–25PubMedGoogle Scholar
  108. 108.
    O’Shea, S., Best, J. M. and Banatvala, J. E. (1983). Viremia, virus excretion, and antibody response after challenge in volunteers with low levels of antibody to rubella virus. J. Infect. Dis., 148, 639–47PubMedCrossRefGoogle Scholar
  109. 109.
    Partridge, J. W., Flewett, T. H. and Whitehead, J. E. M. (1981). Congenital rubella affecting an infant whose mother had rubella antibodies before conception. Br. Med. J., 282, 187–8CrossRefGoogle Scholar
  110. 110.
    Eilard, T. and Strannegard, O. (1974). Rubella re-infection in pregnancy followed by transmission to the fetus. J. Infect. Dis., 129, 594–6PubMedCrossRefGoogle Scholar
  111. I11.
    Vaheri, A., Vesikari, T., Oker-Blom, N., Parkman, P. D., Veronelli, J. and Robbins, T. C. (1972). Isolation of attenuated rubella-vaccine virus from human products of conception and uterine cervix. N. Engl. J. Med., 286, 1071–4PubMedCrossRefGoogle Scholar
  112. 112.
    Hayden, G. C., Herrmann, K. L. and Buimovici-Klein, E. (1980). Subclinical congenital rubella infection associated with maternal rubella vaccination in early pregnancy. J. Pediatr., 96, 869–72PubMedCrossRefGoogle Scholar
  113. 113.
    Preblud, S. R. and Williams, N. M. (1985). Fetal risk associated with rubella vaccine: Implications for vaccination of susceptible women. Obstet. Gyn., 66, 121–3Google Scholar
  114. 114.
    Cooper, L. Z., Ziring, P. R., Ockerse, A. B., Fedun, B. A., Kiely, B. and Krugman, S. (1969). Rubella: Clinical manifestations and management. Am. J. Dis. Child., 118, 18–29PubMedGoogle Scholar
  115. 115.
    Alford, C. A. (1976). Rubella. In Remington, J. S. and Klein, M. O. (eds.) Infectious Diseases of the Fetus and Newborn. pp. 71–106. ( Philadelphia: W. B. Saunders )Google Scholar
  116. 116.
    Alford, C. A., Neva, F. A. and Weller, T. H. (1964). Virologic and serologic studies on human products of conception after maternal rubella. N. Engl. J. Med., 271, 1275–81PubMedCrossRefGoogle Scholar
  117. 117.
    Terry, G. M., Ho-Terry, L., Warren, R. C., Rodeck, C. H., Cohen, A. and Rees, K. R. (1986). First trimester prenatal diagnosis of congenital rubella: A laboratory investigation. Br. Med. J., 292, 930–3CrossRefGoogle Scholar
  118. 118.
    Bellanti, J. A., Artenstein, M. S., Olsen, L. C., Buesher, E. L., Luhrs, C. E. and Milstead, K. L. (1965). Congenital rubella. Clinicopathologic, virologic and immunologic studies. Am. J. Dis. Child., 110, 464–72PubMedGoogle Scholar
  119. 119.
    Tondury, G. and Smith, D. W. (1966). Fetal rubella pathology. J. Pediatr., 58, 867–79Google Scholar
  120. 120.
    Miller, E., Cradock-Watson, J. E. and Pollock, T. M. (1982). Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet, 2, 781–4PubMedCrossRefGoogle Scholar
  121. 121.
    Dudgeon, J. A., Butler, N. R. and Plotkin, S. A. (1964). Further serologic studies on the rubella syndrome. Br. Med. J., 2, 155–60PubMedCrossRefGoogle Scholar
  122. 122.
    Butler, N. R., Dudgeon, J. A., Hayes, H., Peckham, G. S. and Wybar, K. (1965). Persistence of rubella antibody with and without embryopathy. A follow-up study of children exposed to maternal rubell. Br. Med. J., 2, 1027–9PubMedCrossRefGoogle Scholar
  123. 123.
    Rawls, W. E. (1974). Viral persistence in congenital rubella. Prog. Med. Virol., 18, 273–88PubMedGoogle Scholar
  124. 124.
    Yoneda, T., Urade, M., Sakuda, M. and Miyazaki, T. (1986). Altered growth, differentiation, and responsiveness to epidermal growth factor of human embryonic mesenchymal cells of palate by persistent rubella virus infections. J. Clin. Invest., 77, 1613–21PubMedCrossRefGoogle Scholar
  125. 125.
    Hearn, A. M., O’Sullivan, M. A. and Atkins, G. J. (1986). Infection of cultured early mouse embryos with Semliki Forest and rubella viruses. J. Gen. Virol., 67, 1091–8CrossRefGoogle Scholar
  126. 126.
    Dudgeon, J. A. (1969). Congenital rubella: Pathogenesis and immunology. Am. J. Dis. Child., 118, 35–44PubMedGoogle Scholar
  127. 127.
    Desmond, M. M., Wilson, G. S., Melnick, J. L., Singer, D. B., Zion, T. E., Rudolph, A. J., Pineda, R. G., Ziai, M. and Blattner, R. J. (1967). Congenital rubella encephalitis: Course and early sequelae. J. Pediatr., 71, 311–31PubMedCrossRefGoogle Scholar
  128. 128.
    Desmond, M. M., Montgomery, J. R. and Melnick, J. L. (1969). Congenital rubella encephalitis. Am. J. Dis. Child., 118, 30–31PubMedGoogle Scholar
  129. 129.
    Rorke, L. B. (1973). Nervous system lesions in the congenital rubella syndrome. Arch. Otolaryngol., 98, 249–51PubMedGoogle Scholar
  130. 130.
    Monif, G. R. C. and Sever, J. L. (1966). Chronic infection of the central nervous system with rubella virus. Neurology, 16, 111–12PubMedGoogle Scholar
  131. 131.
    Singer, D. B., Rudolph, A. J. and Rosenberg, H. S. (1967). Pathology of the congenital rubella syndrome. J. Pediatr., 71, 665–75PubMedCrossRefGoogle Scholar
  132. 132.
    Menser, M. A., Dods, L. and Harley, J. D. (1967). A twenty-five year follow-up of congenital rubella. Lancet, 2, 1347–50PubMedCrossRefGoogle Scholar
  133. 133.
    Simons, M. J. and Jack, I. (1968). Lymphocyte viraemia in congenital rubella. Lancet, 2, 953–4PubMedCrossRefGoogle Scholar
  134. 134.
    Driscoll, S. G. (1969). Histopathology of gestational rubella. Am. J. Dis. Child., 118, 44–53Google Scholar
  135. 135.
    Hardy, J. (1973). Clinical and development aspects of congenital rubella. Arch. Otolaryngol., 98, 230–6PubMedGoogle Scholar
  136. 136.
    Buimovici-Klein, E., Lang, P. B., Ziring, P. R. and Cooper, L. Z. (1979). Impaired cell-mediated immune response in patients with congenital rubella. Correlation with gestational age at time of infection. Pediatrics, 64, 620–6PubMedGoogle Scholar
  137. 137.
    Enders, G. (1985). Serologic test combinations for safe detection of rubella infections. Rev. Infect. Dis., 7, S113 - S122PubMedCrossRefGoogle Scholar
  138. 138.
    Cooper, L. Z., Florman, A. L., Ziring, P. R. and Krugman, S. (1971). Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 vaccine. Am. J. Dis. Child., 122, 397–403PubMedGoogle Scholar
  139. 139.
    Ueda, K., Nishida, Y., Oshima, K., Yoshikawa, H., Ohashi, K. and Nomaka, S. (1975). Seven year follow-up study of the rubella syndrome in Ryukyu with special references to the persistence of rubella hemagglutination inhibition antibodies. Jpn. J. Microbiol., 19, 181–5PubMedGoogle Scholar
  140. 140.
    Menser, M. A., Slinn, R. F., Dods, L., Hertzberg, R. and Harley, J. D. (1968). Congenital rubella in a mother and son. Aust. Paediatr. J., 4, 200–2Google Scholar
  141. 141.
    DeMazancourt, A., Waxham, M. N., Nicholas, J. C. and Wolinsky, J. S. (1986). Antibody response to the rubella virus structural proteins in infants with the congenital rubella syndrome. J. Med. Virol., 19, 111–22CrossRefGoogle Scholar
  142. 142.
    Tardieu, M., Grospierre, B., Durandy, A. and Griscelli, C. (1980). Circulating immune complexes containing rubella antigens in late-onset rubella syndrome. J. Pediatr., 97, 370–3PubMedCrossRefGoogle Scholar
  143. 143.
    Peckham, C. S. (1972). Clinical and laboratory study of children exposed in utero to maternal rubella. Arch. Dis. Child., 47, 571–7PubMedCrossRefGoogle Scholar
  144. 144.
    Sever, J. L., South, M. A. and Shaver, K. A. (1985). Delayed manifestations of congenital rubella. Rev. Infect. Dis., 7, S164 - S169PubMedCrossRefGoogle Scholar
  145. 145.
    Forrest, J. J., Menser, M. A. and Burgess, J. A. (1971). High frequency of diabetes mellitus in young adults with congenital rubella. Lancet, 2, 332–4PubMedCrossRefGoogle Scholar
  146. 146.
    Ginsberg-Fellner, F., Witt, M. E., Fedun, B., Doberson, M. J., McEvoy, R. C., Copper, L. Z., Notkins, A. L. and Rubinstein, P. (1985). Diabetes mellitus and autoimmunity in patients with the congenital rubella syndrome. Rev. Infect. Dis., 7, S170 - S178PubMedCrossRefGoogle Scholar
  147. 147.
    Cooper, L. Z., Green, R. H., Krugman, S., Giles, J. P. and Mirick, G. S. (1965). Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero. Am. J. Dis. Child., 110, 416–27PubMedGoogle Scholar
  148. 148.
    Townsend, J. J., Baringer, J. R., Wolinsky, J. S., Malamud, N., Mednick, J. P., Panitch, H. S., Scott, R. A. T., Oshiro, L. S. and Cremer, N. E. (1975). Progressive rubella panencephalitis: Late onset after congenital rubella. N. Engl. J. Med., 292, 990–3PubMedCrossRefGoogle Scholar
  149. 149.
    Weil, M. L., Itabashi, H. H., Cremer, N. E., Oshiro, L. S., Lennette, E. H. and Carnay, L. (1975). Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis. N. Engl. J. Med., 292, 994–8PubMedCrossRefGoogle Scholar
  150. 150.
    Jan, J. E., Tingle, A. J., Donald, G., Kettyls, M., Buckler, W. S. J. and Dolman, C. L. (1979). Progressive rubella panencephalitis: Clinical course and response to `Isoprinosine’. Dey. Med. Child. Neurol., 21, 648–52CrossRefGoogle Scholar
  151. 151.
    Lebon, P. and Lyon, G. (1974). Non-congenital rubella encephalitis. Lancet, 2, 468PubMedCrossRefGoogle Scholar
  152. 152.
    Wolinsky, J. S. (1988). Progressive rubella panencephalitis. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology. (In press) (Amsterdam: North-Holland )Google Scholar
  153. 153.
    Wolinsky, J. S., Berg, B. O. and Maitland, C. J. (1976). Progressive rubella panencephalitis. Arch. Neurol., 33, 722–3PubMedGoogle Scholar
  154. 154.
    Dayras, J. C., Lyon, G., Ponsot, G. and Allemon, M. C. (1980). L’encephalite chronique progressive de la rubeole: A propos d’une observation. Semin. Hop. Paris, 56, 1703–8Google Scholar
  155. 155.
    Abe, T., Nakada, T., Hatanaka, H., Tajima, M., Hiraiwa, M. and Ushijima, H. (1983). Myoclonus in a case of suspected progressive rubella panencephalitis. Arch. Neurol., 40, 98–100PubMedGoogle Scholar
  156. 156.
    Wolinsky, J. S., Waxham, M. N., Hess, J. L., Townsend, J. J. and Baringer, J. R. (1982) Immunochemical features of a case of progressive rubella panencephalitis. Clin. Exp. Immunol., 48, 359–66PubMedGoogle Scholar
  157. 157.
    Weil, M. L., Perrin, L., Buimovici-Klein, E., Oldstone, M. and Cooper, L. Z. (1976). Immunologic abnormalities associated with chronic progressive panencephalitis due to congenital infection with rubella. Clin. Res., 24, 185Google Scholar
  158. 158.
    Coyle, P. K. and Wolinsky, J. S. (1981). Characterization of immune complexes in progressive rubella panencephalitis. Ann. Neurol., 9, 557–62PubMedCrossRefGoogle Scholar
  159. 159.
    Wolinsky, J. S., Dau, P. C., Buimovici-Klein, E., Mednick, J., Berg, B. O., Lang, P. B. and Cooper, L. Z. (1979). Progressive rubella panencephalitis: Immunovirological studies and results of isoprinosine therapy. Clin. Exp. Immunol., 35, 397–404PubMedGoogle Scholar
  160. 160.
    Cremer, N. E., Oshiro, L. S., Weil, M. L., Lennette, E. H., Itabashi, H. and Carnay, L. (1975). Isolation of rubella virus from brain in chronic progressive panencephalitis. J. Gen. Virol., 29, 143–53PubMedCrossRefGoogle Scholar
  161. 161.
    Wolinsky, J. S. (1978). Progressive rubella panencephalitis. In Vinken, P. J. and Bruyn, G. W. (eds.) Handbook of Clinical Neurology. Vol. 34, pp. 331–41. ( Amsterdam: North-Holland )Google Scholar
  162. 162.
    Vandvik, B., Norrby, E., Steen-Johnson, J. and Stensvold, K. (1978). Progressive rubella panencephalitis: Synthesis of oligoclonal virus-specific IgG antibodies and homogenous free light chains in the central nervous system. Eur. Neurol., 17, 13–22PubMedCrossRefGoogle Scholar
  163. 163.
    Townsend, J. J., Wolinsky, J. S. and Baringer, J. R. (1976). The neuropathology of progressive rubella panencephalitis. Brain, 99, 81–90PubMedCrossRefGoogle Scholar
  164. 164.
    Townsend, J. J., Stroop, W. G., Baringer, J. R., Wolinksy, J. S., McKerrow, J. H. and Berg, B. O. (1982). Neuropathology of progressive rubella panencephalitis after childhood rubella. Neurology, 32, 185–90PubMedGoogle Scholar
  165. 165.
    Rorke, L. B. and Spiro, A. J. (1967). Cerebral lesions in congenital rubella syndrome. J. Pediatr., 70, 243–55PubMedCrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1988

Authors and Affiliations

  • Jerry S. Wolinsky

There are no affiliations available

Personalised recommendations